BioIntelliSense, Inc. research brief
CIK 1824134
Generated Nov. 18, 2026, 9:13 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: GOLDEN Colorado. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- June 4, 2026 · D/A · 0001824134-26-000001 · Source evidence
Reported offering amount: 58350027 USD. Reported amount sold: 58349365 USD.
- Dec. 19, 2025 · D · 0001824134-25-000003 · Source evidence
Reported offering amount: 58350027 USD. Reported amount sold: 58050027 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “BioIntelliSense, Inc. research brief,” CIK 1824134, retrieved Nov. 18, 2026, 9:13 p.m.. Cite the specific accessions used. No amounts have been summed.